Astrazeneca Pharma India informs about press release

11 Mar 2024 Evaluate
Astrazeneca Pharma India has enclosed copy of press release in connection with a Distribution and Promotion Agreement entered into by the Company with Mankind Pharma for the distribution of budesonide and formoterol fumarate dihydrate (brand name Symbicort) in India. Further, details as required under the SEBI Circular SEBI/HO/CFD/CFD-PoD1/P/CIR/2023/123 dated July 13, 2023 attached as Annexure - A, in this regard.

The above information is a part of company’s filings submitted to BSE. 

Astrazeneca Pharma I Share Price

9067.30 158.60 (1.78%)
29-Dec-2025 14:12 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1716.00
Dr. Reddys Lab 1266.30
Cipla 1496.65
Zydus Lifesciences 906.20
Lupin 2084.40
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×